首页> 美国卫生研究院文献>Experimental Diabetes Research >Effects of a Patient-Provider Collaborative Medication-Planning Tool: A Randomized Controlled Trial
【2h】

Effects of a Patient-Provider Collaborative Medication-Planning Tool: A Randomized Controlled Trial

机译:病人提供者协作性药物治疗计划工具的效果:随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Among patients with various levels of health literacy, the effects of collaborative, patient-provider, medication-planning tools on outcomes relevant to self-management are uncertain. Objective. Among adult patients with type II diabetes mellitus, we tested the effectiveness of a medication-planning tool (Medtable™) implemented via an electronic medical record to improve patients' medication knowledge, adherence, and glycemic control compared to usual care. Design. A multicenter, randomized controlled trial in outpatient primary care clinics. 674 patients received either the Medtable tool or usual care and were followed up for up to 12 months. Results. Patients who received Medtable had greater knowledge about indications for medications in their regimens and were more satisfied with the information about their medications. Patients' knowledge of drug indication improved with Medtable regardless of their literacy status. However, Medtable did not improve patients' demonstrated medication use, regimen adherence, or glycemic control (HbA1c). Conclusion. The Medtable tool supported provider/patient collaboration related to medication use, as reflected in patient satisfaction with communication, but had limited impact on patient medication knowledge, adherence, and HbA1c outcomes. This trial is registered with ClinicalTrials.gov .
机译:在具有不同健康素养水平的患者中,不确定协作,患者提供者,药物规划工具对与自我管理有关的结果的影响。目的。在成年II型糖尿病患者中,我们测试了通过电子病历实施的药物规划工具(Medtable™)的有效性,该药物规划工具与常规护理相比可改善患者的药物知识,依从性和血糖控制。设计。门诊初级保健诊所的多中心随机对照试验。 674名患者接受了Medtable工具或常规护理,并接受了长达12个月的随访。结果。接受Medtable的患者对他们的治疗方案中的药物适应症有更多的了解,并对他们的药物信息更加满意。 Medtable可提高患者对药物适应症的了解,无论其识字状况如何。但是,Medtable并不能改善患者证明的药物使用,方案依从性或血糖控制(HbA1c)。结论。 Medtable工具支持与药物使用相关的提供者/患者协作,这反映在患者对沟通的满意度中,但对患者药物知识,依从性和HbA1c结果的影响有限。该试验已在ClinicalTrials.gov上注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号